| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1956 | 2020 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 594 | 2023 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 326 | 2021 |
| Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer A Addeo, PK Shah, N Bordry, RD Hudson, B Albracht, M Di Marco, ... Cancer cell 39 (8), 1091-1098. e2, 2021 | 245 | 2021 |
| Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies RF Chemaly, DP Shah, MJ Boeckh Clinical infectious diseases 59 (suppl_5), S344-S351, 2014 | 217 | 2014 |
| How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients F El Chaer, DP Shah, RF Chemaly Blood, The Journal of the American Society of Hematology 128 (23), 2624-2636, 2016 | 199 | 2016 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 190 | 2021 |
| Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer MA Liss, JR White, M Goros, J Gelfond, R Leach, T Johnson-Pais, Z Lai, ... European urology 74 (5), 575-582, 2018 | 163 | 2018 |
| Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections DP Shah, SS Ghantoji, JN Shah, KK El Taoum, Y Jiang, U Popat, ... Journal of antimicrobial chemotherapy 68 (8), 1872-1880, 2013 | 162 | 2013 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 148 | 2020 |
| Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections DP Shah, SS Ghantoji, EJ Ariza-Heredia, JN Shah, KK El Taoum, ... Blood, The Journal of the American Society of Hematology 123 (21), 3263-3268, 2014 | 141 | 2014 |
| Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review DP Shah, PK Shah, JM Azzi, RF Chemaly Cancer letters 370 (2), 358-364, 2016 | 111 | 2016 |
| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of Oncology 33 (3), 340-346, 2022 | 101 | 2022 |
| Management of respiratory viral infections in hematopoietic cell transplant recipients DP Shah, SS Ghantoji, VE Mulanovich, EJ Ariza-Heredia, RF Chemaly American journal of blood research 2 (4), 203, 2012 | 100 | 2012 |
| Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: the REACT study RF Chemaly, L El Haddad, DJ Winston, SD Rowley, KM Mulane, ... Clinical Infectious Diseases 71 (9), 2365-2374, 2020 | 86 | 2020 |
| Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients E Frenzel, RF Chemaly, E Ariza-Heredia, Y Jiang, DP Shah, G Thomas, ... American journal of infection control 44 (9), 1016-1021, 2016 | 81 | 2016 |
| Outcomes of influenza infections in hematopoietic cell transplant recipients: application of an immunodeficiency scoring index J Kmeid, J Vanichanan, DP Shah, F El Chaer, J Azzi, EJ Ariza-Heredia, ... Biology of blood and marrow transplantation 22 (3), 542-548, 2016 | 80 | 2016 |
| Utility of the enzyme-linked immunospot interferon-γ–release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients L Nesher, DP Shah, EJ Ariza-Heredia, JM Azzi, HK Siddiqui, SS Ghantoji, ... The Journal of infectious diseases 213 (11), 1701-1707, 2016 | 76 | 2016 |
| The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients L El Haddad, E Ariza-Heredia, DP Shah, Y Jiang, T Blanchard, ... The Journal of infectious diseases 219 (6), 898-907, 2019 | 72 | 2019 |
| Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice EJ Ariza‐Heredia, AM Gulbis, KR Stolar, P Kebriaei, DP Shah, ... Transplant Infectious Disease 16 (6), 878-886, 2014 | 67 | 2014 |
